Malaysian Companies Increasingly Looking Beyond Domestic Markets for Growth and Capital Access, Says ARC Group

Malaysian Companies Increasingly Looking Beyond Domestic Markets for Growth and Capital Access, Says ARC Group

Kuala Lumpur, May 6, 2026 — ARC Group hosted a closed-door media luncheon in Kuala Lumpur, bringing together leading Malaysian media representatives to discuss how the capital markets landscape is evolving for Malaysian and Southeast Asian companies amid shifting global financing conditions.

The discussion highlighted a growing trend of Malaysian companies increasingly exploring international capital markets, particularly in U.S. capital markets, as businesses seek broader investor access, stronger liquidity, and more competitive valuation environments.

ARC Group hosting a closed-door media luncheon in Kuala Lumpur, May 6, 2026

According to ARC Group Partner Datuk Seri Paul Chong, the tightening of private market financing is no longer a temporary market cycle, but part of a broader structural shift affecting how companies approach growth and fundraising.

“Private equity and venture capital investors are becoming increasingly selective, with capital concentrating around a smaller number of sectors and opportunities,” he said.

“As a result, companies can no longer wait until the last minute to think about capital markets. Decisions around fundraising strategy and listing pathways now need to happen much earlier.”

A key focus of the session was the increasing appeal of U.S. exchanges such as Nasdaq and the New York Stock Exchange for Malaysian mid-market companies.

“Access to global investors, deeper liquidity, and stronger valuation benchmarks are among the key drivers behind this shift,” Chong added.

“It’s no longer just about raising capital locally, companies are thinking globally from day one.”

ARC Group also noted that valuation gaps between U.S. and Asian markets continue to influence listing strategies, with many APAC companies exploring overseas markets to access broader institutional investor participation and increased market visibility.

From an execution perspective, ARC Group Securities CEO Ian Hanna emphasized that companies are becoming more strategic in how they approach international listings and capital raising.

“In today’s environment, companies are not delaying , they are becoming more deliberate and strategic,” he said.

“Execution, structuring, and access to the right investor base have become increasingly important, particularly for companies evaluating cross-border opportunities.”

Hanna also highlighted that international exchanges offer flexibility for growth-stage companies that may not yet meet profitability thresholds required in certain domestic markets.

From an investor standpoint, ARC Group Head of Asset & Wealth Management Nigel Wong noted that Southeast Asia is increasingly attracting global investor attention, supported by long-term structural growth, resilient foreign direct investment flows, and ongoing regional economic expansion.

“With investors actively seeking growth opportunities beyond traditional markets, Southeast Asia is emerging as an increasingly important pipeline for global capital allocation,” Wong said.

He added that ARC Group is seeing growing interest from international investors and family offices looking for exposure to ASEAN-focused opportunities, particularly in sectors such as digital infrastructure, advanced manufacturing, and clean energy.

The discussion also touched on Malaysia’s domestic financing landscape, where funding gaps for small and mid-sized enterprises continue to reinforce the importance of alternative capital market solutions and international financing access.

The media luncheon formed part of ARC Group’s broader engagement surrounding the Capital Markets and M&A Forum 2026 Malaysia Edition, which marked the fourth consecutive year of the firm hosting the event in Kuala Lumpur.

The forum has grown into one of the largest capital markets gatherings globally, attracting over 500 senior executives and market participants. This includes a strong domestic presence with close to 400 delegates from Malaysia, alongside a significant international contingent from more than 16 countries, including the United States, United Kingdom, China, India, New Zealand, Australia, South Africa and Uganda.

It continues to serve as a key platform for dialogue on global capital markets, cross-border M&A, and international growth strategies, reflecting ARC Group’s ongoing commitment to strengthening capital markets connectivity between Southeast Asia and global investors.

ARC Group hosting a closed-door media luncheon in Kuala Lumpur, May 6, 2026

ARC Group hosting a closed-door media luncheon in Kuala Lumpur, May 6, 2026

ARC Group hosting a closed-door media luncheon in Kuala Lumpur, May 6, 2026

ARC Group hosting a closed-door media luncheon in Kuala Lumpur, May 6, 2026

ARC Group hosting a closed-door media luncheon in Kuala Lumpur, May 6, 2026

ARC Group hosting a closed-door media luncheon in Kuala Lumpur, May 6, 2026

Media coverage:

The media session has garnered coverage across leading Malaysian outlets, including The Star, with additional interest from broadcast and financial media such as New Straits Times Press, Astro Awani, and Radio Televisyen Malaysia.

This broad coverage across print, digital, and broadcast platforms reflects strong media engagement and reinforces ARC Group’s key narratives on Malaysia’s evolving role in global capital markets and cross-border capital flows.

The Star ARC Group sees a growing push for Malaysian firms to list overseas

Astro Awani : Malaysia emerges as a two-way capital market

NSTP : Nasdaq draws Malaysian firms eyeing global capital

RTM Online (Malay) : Pasaran modal global alternatif pembiayaan

RTM Video (Malay)

RTM Video (English)

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission